Evidence map›Paper›PMID 21576259›Full record

ArticleGenes & development2011

Limiting Ago protein restricts RNAi and microRNA biogenesis during early development in Xenopus laevis.

Elsebet Lund, Michael D Sheets, Susanne Blaser Imboden, James E Dahlberg

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. MicroRNA regulation of autophagy in cardiovascular disease.Frontiers in bioscience (Landmark edition) · 2017
    Review
  14. Pigmy MicroRNA: surveillance cops in Therapies kingdom.Molecular medicine (Cambridge, Mass.) · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. RNA-based drugs and vaccines.Expert review of vaccines · 2015
    Review
  19. Article
  20. Aberrant expression of cyclin D1 in cancer.Signal transduction insights · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elsebet LundDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Michael D Sheets
Susanne Blaser Imboden
James E Dahlberg
University of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We show that, in Xenopus laevis oocytes and early embryos, double-stranded exogenous siRNAs cannot function as microRNA (miRNA) mimics in either deadenylation or guided mRNA cleavage (RNAi). Instead, siRNAs saturate and inactivate maternal Argonaute (Ago) proteins, which are present in low amounts but are needed for Dicer processing of pre-miRNAs at the midblastula transition (MBT). Consequently, siRNAs impair accumulation of newly made miRNAs, such as the abundant embryonic pre-miR-427, but inhibition dissipates upon synthesis of zygotic Ago proteins after MBT. These effects of siRNAs, which are independent of sequence, result in morphological defects at later stages of development. The expression of any of several exogenous human Ago proteins, including catalytically inactive Ago2 (Ago2mut), can overcome the siRNA-mediated inhibition of miR-427 biogenesis and function. However, expression of wild-type, catalytically active hAgo2 is required to elicit RNAi in both early embryos and oocytes using either siRNA or endogenous miRNAs as guides. The lack of endogenous Ago2 endonuclease activity explains why these cells normally are unable to support RNAi. Expression of catalytically active exogenous Ago2, which appears not to perturb normal Xenopus embryonic development, can now be exploited for RNAi in this vertebrate model organism.

Indexed as

Gene Expression Regulation, DevelopmentalRNA InterferenceAnimalsArgonaute ProteinsEmbryo, NonmammalianEukaryotic Initiation Factor-2Eukaryotic Initiation FactorsHumansMicroRNAsOocytesRibonuclease IIIRNA, Small InterferingRNA StabilityXenopus laevisAGO2 protein, humanArgonaute ProteinsEukaryotic Initiation Factor-2Eukaryotic Initiation FactorsMicroRNAsRibonuclease IIIRNA, Small Interfering

Identifiers

PMID21576259
PMCPMC3110951
OpenAlexW2113133164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.